Cell Signalling and its Applications in Therapeutics and Disease (C7118)
15 credits, Level 6
This module looks at the major signalling pathways in cells and how perturbations of these can result in disease processes such as hypertension, cancer, gigantism, cholera, secretory diarrhea, polycystic kidney disease and septic shock.
You learn how a knowledge of these pathways has led to the design and use of specific pharmacological agents to target these pathways for therapeutic intervention.
The signalling pathways covered will include Ca2+, cyclic nucleotides, nitric oxide and guanylate cyclase, MAPK kinase pathways, PI-3-kinase and PKB, Jak/Stat pathways and integrins.
Teaching and assessment
We’re currently reviewing teaching and assessment of our modules in light of the COVID-19 situation. We’ll publish the latest information as soon as possible.
Contact hours and workload
This module is approximately 150 hours of work. This breaks down into about 35 hours of contact time and about 115 hours of independent study. The University may make minor variations to the contact hours for operational reasons, including timetabling requirements.
This module is running in the academic year 2021/22. We also plan to offer it in future academic years. However, there may be changes to this module in response to COVID-19, or due to staff availability, student demand or updates to our curriculum. We’ll make sure to let our applicants know of material changes to modules at the earliest opportunity.
It may not be possible to take some module combinations due to timetabling constraints. The structure of some courses means that the modules you choose first may determine whether later modules are core or optional.
This module is offered on the following courses: